Dr. Sakamoto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5200 Dtc Pkwy
Ste 400
Greenwood Village, CO 80111Phone+1 303-745-0000Fax+1 303-773-3101
Education & Training
- University of ColoradoResidency, Internal Medicine, 2017 - 2020
- Tufts University School of MedicineClass of 2017
Certifications & Licensure
- CO State Medical License 2020 - 2025
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 4 citationsExceptional response to lorlatinib and cabozantinib in ROS1-rearranged NSCLC with acquired F2004V and L2086F resistance.Mandy Sakamoto, Tejas Patil
NPJ Precision Oncology. 2023-06-08 - 3 citationsSugemalimab, a novel PD-L1 inhibitor for treatment of advanced or metastatic non-small cell lung cancer.Mandy Sakamoto, Antonio Jimeno
Drugs of Today. 2023-03-01 - 25 citationsROS1 Targeted Therapies: Current Status.Christine M Azelby, Mandy R Sakamoto, Daniel W. Bowles
Current Oncology Reports. 2021-06-14
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: